We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"Thyroid cancer. An increased risk for medullary thyroid carcinoma with GLP-1 RAs has been hypothesised in susceptible individuals, although this ..."
"Medullary thyroid cancer develops from the C cells of the thyroid gland, which normally produce calcitonin a hormone that helps control the amount ..."
"Libretto-432 is known to be positive for event-free survival versus chemo, and could expand Retevmo's reach in lung cancer, where the drug is ..."
"Additionally, Lilly must collate more data on Foundayo's impact on the incidence of medullary thyroid carcinoma over a 15-year period. Eli Lilly ..."
"... RET inhibitor lunbotinib fumarate (A400/EP0031, [1]) and novel ... RET inhibitor lunbotinib fumarate (A400/EP0031, ) and ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.